1. Introduction
===============

Previous chemical investigations on the octocorals belonging to the genus *Cladiella* have resulted in a series of interesting eunicellin-based (2,11-cyclized cembranoid) diterpenoids \[[@b1-marinedrugs-08-02936]--[@b6-marinedrugs-08-02936]\], and the compounds of this type have been found to possess complex structures and various bioactivities \[[@b1-marinedrugs-08-02936]--[@b3-marinedrugs-08-02936],[@b5-marinedrugs-08-02936]--[@b11-marinedrugs-08-02936]\]. In continuation of our search for bioactive substances from the marine invertebrates distributed in the tropical West Pacific Ocean, an Indonesian octocoral identified as *Cladiella* sp. was studied, and its organic extract exhibited cytotoxicity toward DLD-1 (human colorectal adenocarcinoma), HL-60 (human promyelocytic leukemia cells), and P388D1 (macrophage-like murine tumor cells), with IC~50~ = 2.7, 8.9, 7.2 μg/mL, respectively. Two new eunicellins, cladielloides A (**1**) and B (**2**), were isolated from this marine organism. In this paper, we report the isolation, structure determination, and bioactivity of the above new diterpenoids **1** and **2** ([Scheme 1](#f2-marinedrugs-08-02936){ref-type="fig"}).

2. Results and Discussion
=========================

Cladielloide A (**1**) was isolated as a colorless oil and the molecular formula for this compound was determined to be C~26~H~40~O~7~ (seven degrees of unsaturation) by HRESIMS (C~26~H~40~O~7~ + Na, *m*/*z* 487.2674, calculated 487.2672). The IR spectrum of **1** showed bands at 3460 and 1734 cm^−1^, consistent with the presence of hydroxy and ester groups. From the ^1^H and ^13^C NMR spectra ([Table 1](#t1-marinedrugs-08-02936){ref-type="table"}), **1** was found to possess a trisubstituted olefin (*δ*~H~ 5.43, 1H, m, H-12; *δ*~C~ 132.1, s, C-11; 122.2, d, C-12), an exocyclic carbon-carbon double bond (*δ*~H~ 5.21, 1H, s, H-16a; 5.58, 1H, s, H-16b; *δ*~C~ 147.6, s, C-7; 115.2, t, C-16), an acetoxy group (*δ*~H~ 2.14, 3H, s; *δ*~C~ 20.6, q; 171.1, s), and a 2-hydroxybutyrate (*δ*~H~ 1.03, 3H, t, *J* = 7.2 Hz; 1.91, 2H, m; 4.86, 1H, dd, *J* = 6.8, 6.0 Hz; *δ*~C~ 9.3, q; 24.3, t; 74.1, d; 171.4, s) moiety. Thus, from the above data, four degrees of unsaturation were accounted for and compound **1** must be a tricyclic compound.

In the ^1^H NMR spectrum of **1**, two doublets at *δ*~H~ 0.92 and 0.83 (each 3H, d, *J* = 6.4 Hz, H~3~-19 and H~3~-20) were deduced from two methyls of an isopropyl group. A singlet of the tertiary methyl bonded to an oxygenated carbon was due to the resonance of signal at *δ*~H~ 1.37 (3H, s, H~3~-15). In addition, a suite of resonances of proton signals at *δ*~H~ 2.74 (1H, m, H-1), 2.63 (1H, br s, H-10), 3.86 (1H, d, *J* = 8.0 Hz, H-2), 4.16 (1H, dt, *J* = 3.6, 3.2 Hz, H-9), and carbon signals at *δ*~C~ 39.7 (d, C-1), 44.6 (d, C-10), 87.1 (d, C-2), and 81.3 (d, C-9), indicated the presence of a tetrahydrofuran structural unit. Based on the above data, the proposed skeleton of **1** was suggested to be a eunicellin-based metabolite.

From the ^1^H--^1^H COSY spectrum of **1**, it was possible to identify the separate spin systems among H-1/H-2; H-4/H~2~-5/H-6; H~2~-8/H-9/H-10; and H-10/H-1 ([Table 1](#t1-marinedrugs-08-02936){ref-type="table"}). These data, together with the HMBC correlations between H-1/C-2, −3, −10; H-2/C-3, −4, −9; H-4/C-3, −6; H~2~-5/C-3, −4, −6, −7; and H~2~-8/C-6, −7, −9, −10, established the connectivity from C-1 to C-10 within the ten-membered ring ([Table 1](#t1-marinedrugs-08-02936){ref-type="table"}). An exocyclic carbon-carbon double bond at C-7 was confirmed by the HMBC correlations between H~2~-16/C-6, −7, −8 and H~2~-8/C-16. The hydroxy proton signal at *δ*~H~ 2.84 was revealed by its ^1^H--^1^H COSY correlations to H-6 (*δ*~H~ 4.21), indicating its attachment to C-6. The location of 2-hydroxybutyrate group in **1** was confirmed by an HMBC correlation between H-4 (*δ*~H~ 5.14) and the 2-hydroxybutyrate carbonyl (*δ*~C~ 171.4, s). Thus, the remaining acetate ester was at C-3, an oxygenated quaternary carbon which bonded to the C-15 tertiary methyl and is confirmed by the HMBC correlations between H-2/C-15; H-4/C-15; and H~3~-15/C-2, −3, −4. The ether bridge between C-2 and C-9 was supported by an HMBC correlation between H-2/C-9. The 1-isopropyl-4-methylcyclohexene ring, which is fused to the ten-membered ring at C-1 and C-10, was elucidated by the ^1^H--^1^H COSY correlations between H-12/H~2~-13/H-14/H-1; H-14/H-18; and H-18/H~3~-19(H~3~-20) and further supported by the HMBC correlations between H-1/C-11, −14; H-2/C-14; H-10/C-11; H~3~-17/C-10; and H-18/C-1. The vinyl methyl at C-11 was confirmed by the HMBC correlations between H~3~-17/C-10, −11, −12 and further supported by the allylic coupling between the olefin proton H-12 and H~3~-17 (*J* = 0.8 Hz). Therefore, the planar structure of **1** was established.

The relative configuration of **1** was elucidated from the interactions observed in a NOESY experiment. In the NOESY experiment of **1** ([Table 2](#t2-marinedrugs-08-02936){ref-type="table"}), the correlations between H-1 with H-4 and H-10, indicated that these protons are situated on the same face and assigned as β protons. H-2 exhibited interactions with H-14 and H~3~-15 and no correlation was found between H-1 and H-2, indicating that H-2, H-14, and Me-15 should be α-oriented. H-6 correlated with one proton of C-5 methylene (*δ*~H~ 2.97), but not with H-4, reflecting the α-orientation of H-6. Furthermore, H-9 correlated with H~2~-8 and H~3~-17. From consideration of molecular models, H-9 was found to be reasonably close to H~2~-8 and H~3~-17, when H-9 was α-oriented in **1**.

In order to determine the absolute configuration, the eunicellin **1** was treated with (−) or (+)-MTPA chloride to yield the (*S*)- and (*R*)-MTPA esters **1a** and **1b**, respectively \[[@b12-marinedrugs-08-02936]--[@b14-marinedrugs-08-02936]\]. Comparison of the ^1^H NMR chemical shifts for **1a** and **1b** (Δ values shown in [Figure 1](#f1-marinedrugs-08-02936){ref-type="fig"}) led to the assignment of the *S*-configuration at C-6. The C-24 hydroxy group in the 2-hydroxybutyrate moiety was also assigned as *R*-configuration. Therefore, the absolute configurations of all chiral centers of **1** were assigned as 1*R*, 2*R*, 3*R*, 4*S*, 6*S*, 9*R*, 10*R*, 14*R*, 24*R*.

Cladielloide B (**2**) had the same molecular formula as that of **1**, C~26~H~40~O~7~, as determined by HRESIMS (C~26~H~40~O~7~ + Na, *m*/*z* 487.2675, calculated 487.2672). The spectral data (1D, 2D NMR ([Table 3](#t3-marinedrugs-08-02936){ref-type="table"}), IR, and MS) were similar to those of **1**. However, the polarity of **2**, which was checked by TLC, was substantially different from that of **1**, indicating that these two compounds are isomers. In the ^1^H NMR spectrum of **2**, an acetate methyl was observed at *δ*~H~ 2.14 (3H, s). The additional acyl group was found to be a 2-hydroxybutyrate group, which showed six contiguous protons (*δ*~H~ 1.02, 3H, t, *J* = 7.2 Hz; 1.91, 2H, m; 4.87, 1H, dd, *J* = 6.8, 6.0 Hz). The ^13^C NMR signal at *δ*~C~ 170.2 (s) correlated with the signal of an oxymethine proton at *δ*~H~ 4.87 in the HMBC spectrum and was consequently assigned as the carbon atom of the 2-hydroxybutyrate carbonyl. A correlation observed in the HMBC experiment of **2** further revealed the connectivity between H-4 (*δ*~H~ 5.21) and the carbonyl carbon (*δ*~C~ 170.2) of 2-hydroxybutyrate unit and demonstrated the location of the 2-hydroxybutyrate to be at C-4. The position of acetoxy group at C-6 was also confirmed by the connectivity between the oxymethine proton at *δ*~H~ 4.66 (H-6) and the ester carbonyl at *δ*~C~ 171.6 (s) in the HMBC spectrum of **2**. Thus, the remaining hydroxy group should be positioned at C-3. In addition, by comparison of the NOESY correlations of **2** with those of **1**, the chiral centers of **2** were confirmed to be the same as those of **1**.

The cytotoxicity of metabolites **1** and **2** toward various tumor cell lines, including DLD-1, HL-60, CCRF-CEM (human T-cell acute lymphoblastic leukemia), and P388D1 cells was evaluated. The results, in [Table 4](#t4-marinedrugs-08-02936){ref-type="table"}, show that eunicellin **2** exhibited moderate cytotoxicity toward CCRF-CEM cells.

The *in vitro* anti-inflammatory effects of metabolites **1** and **2** were tested. Metabolite **2** displayed significant inhibitory effects on superoxide anion generation and elastase release by human neutrophils at 10 μg/mL ([Table 5](#t5-marinedrugs-08-02936){ref-type="table"}).

3. Experimental
===============

3.1. General Experimental Procedures
------------------------------------

Optical rotation values were measured with a JASCO P-1010 digital polarimeter at 25 °C. Infrared spectra were obtained on a VARIAN DIGLAB FTS 1000 FT-IR spectrometer. The NMR spectra were recorded on a VARIAN MERCURY PLUS 400 FT-NMR at 400 MHz for ^1^H and 100 MHz for ^13^C, in CDCl~3~ at 25 °C. Proton chemical shifts were referenced to the residual CHCl~3~ signal (*δ*~H~ 7.26 ppm). ^13^C NMR spectra were referenced to the center peak of CDCl~3~ at *δ*~C~ 77.1 ppm. ESIMS and HRESIMS data were recorded on a BRUKER APEX II mass spectrometer. Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. HPLC was performed using a system comprised of a HITACHI L-7100 pump, a HITACHI photodiode array detector L-7455, and a RHEODYNE 7725 injection port. A normal phase column (Hibar 250 × 10 mm, Merck, silica gel 60, 5 μm,) was used for HPLC.

3.2. Animal Material
--------------------

The octocoral *Cladiella* sp. were collected from Indonesia in 2004 and stored in a freezer until extraction. A voucher specimen was deposited in the National Museum of Marine Biology and Aquarium, Taiwan (NMMBA). This organism was identified by comparison with previous descriptions \[[@b15-marinedrugs-08-02936],[@b16-marinedrugs-08-02936]\].

3.3. Extraction and Isolation
-----------------------------

Slices of *Cladiella* sp. (wet weight 924 g) were extracted with a mixture of MeOH and CH~2~Cl~2~ (1:1) and the residue was partitioned between EtOAc and H~2~O. The EtOAc layer was subjected to silica gel column chromatography and eluted using a mixture of *n*-hexane and EtOAc (stepwise, 100:1 to pure EtOAc) to obtain 19 fractions A--S. Fractions K and N were repurified by normal phase HPLC, using the mixture of *n*-hexane/ethyl acetate to afford **2** (2.4 mg, 5.5:1) and **1** (7.9 mg, 3:1), respectively.

Cladielloide A (**1**). Colorless oil; \[α\]~D~^23^ −24° (*c* 0.4, CHCl~3~); IR (neat) ν~max~ 3460, 1734 cm^−1;\ 1^H (CDCl~3~, 400 MHz) and ^13^C (CDCl~3~, 100 MHz) NMR data, see [Table 1](#t1-marinedrugs-08-02936){ref-type="table"}; ESIMS *m*/*z* 487 (M + Na)^+^; HRESIMS *m*/*z* 487.2674 (calculated for C~26~H~40~O~7~ + Na, 487.2672).

Cladielloide B (**2**). Colorless oil; \[α\] ~D~^23^ −10° (*c* 0.1, CHCl~3~); IR (neat) ν~max~ 3446, 1738 cm^−1;\ 1^H (CDCl~3~, 400 MHz) and ^13^C (CDCl~3~, 100 MHz) NMR data, see [Table 3](#t3-marinedrugs-08-02936){ref-type="table"}; ESIMS *m*/*z* 487 (M + Na)^+^; HRESIMS *m*/*z* 487.2675 (calculated for C~26~H~40~O~7~ + Na, 487.2672).

3.4. Preparation of (*S*)- and (*R*)-MTPA Esters of Cladielloide A (**1**)
--------------------------------------------------------------------------

To a solution of **1** (1 mg) in pyridine (0.4 mL), *R*-(−)-α-methoxy-α-(trifluoromethyl) phenylacetyl (MPTA) chloride (25 μL) was added, and the mixture was allowed to stand for 24 h at room temperature. The reaction was quenched by addition of 1.0 mL of water, and the mixture was subsequently extracted with EtOAc (3 × 1.0 mL). The EtOAc-soluble layers were combined, dried over anhydrous MgSO~4~ and evaporated. The residue was subjected to column chromatography over silica gel using *n*-hexane--EtOAc (13:2) to yield the (*S*)-MTPA ester, **1a** (0.7 mg, 44%). The same procedure was used to prepare the (*R*)-MTPA ester, **1b** (1.4 mg, 89%), from the reaction of (*S*)-MPTA chloride with **1** in pyridine. The key ^1^H NMR chemical shift differences Δ*δ* (*δ~S~* − *δ~R~*) in ppm for the MTPA esters of **1** are shown in [Figure 1](#f1-marinedrugs-08-02936){ref-type="fig"}.

3.5. Cytotoxicity Testing
-------------------------

The cytotoxicity of compounds **1** and **2** was assayed with a modification of the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] colorimetric method. Cytotoxicity assays was carried out according to the procedures described previously \[[@b17-marinedrugs-08-02936],[@b18-marinedrugs-08-02936]\].

3.6. Human Neutrophil Superoxide Anion Generation and Elastase Release
----------------------------------------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Superoxide generation and elastase release were carried out according to the procedures described previously \[[@b19-marinedrugs-08-02936],[@b20-marinedrugs-08-02936]\]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome *c*. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate.
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![The structures of cladielloides A (**1**) and B (**2**).](marinedrugs-08-02936f2){#f2-marinedrugs-08-02936}

###### 

^1^H and ^13^C NMR data, ^1^H--^1^H COSY, and HMBC correlations for diterpenoid **1**.

  C/H                  ^1^H [a](#tfn1-marinedrugs-08-02936){ref-type="table-fn"}           ^13^C [b](#tfn2-marinedrugs-08-02936){ref-type="table-fn"}   ^1^H--^1^H COSY                                              HMBC (H→C)               
  -------------------- ------------------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------ ------------------------ -----------------------------------------------------------
  1                    2.74 m                                                              39.7                                                         \(d\) [d](#tfn4-marinedrugs-08-02936){ref-type="table-fn"}   H-2, H-10, H-14          C-2, −3, −10, −11, −14
  2                    3.86 d (8.0) [c](#tfn3-marinedrugs-08-02936){ref-type="table-fn"}   87.1                                                         \(d\)                                                        H-1                      C-3, −4, −9, −14, −15
  3                                                                                        74.6                                                         \(s\)                                                                                 
  4                    5.14 dd (4.4, 3.6)                                                  74.4                                                         \(d\)                                                        H~2~-5                   C-3, −6, −15, −23
  5α                   2.97 ddd (16.0, 4.4, 2.8)                                           37.2                                                         \(t\)                                                        H-4, H-5β, H-6           C−3, −4
   β                   1.75 ddd (16.0, 5.6, 3.6)                                                                                                                                                                     H-4, H-5α, H-6           C-4, −6, −7
  6                    4.21 br s                                                           72.6                                                         \(d\)                                                        H~2~-5, OH-6             n.o. [e](#tfn5-marinedrugs-08-02936){ref-type="table-fn"}
  7                                                                                        147.6                                                        \(s\)                                                                                 
  8                    2.35 br d (2.4)                                                     40.0                                                         \(t\)                                                        H-9                      C-6, −7, −9, −10, −16
  9                    4.16 dt (3.6, 3.2)                                                  81.3                                                         \(d\)                                                        H~2~-8, H-10             n.o.
  10                   2.63 br s                                                           44.6                                                         \(d\)                                                        H-1, H-9                 C-11
  11                                                                                       132.1                                                        \(s\)                                                                                 
  12                   5.43 m                                                              122.2                                                        \(d\)                                                        H~2~-13, H~3~-17         n.o.
  13α                  2.10 m                                                              22.8                                                         \(t\)                                                        H-12, H-13β, H-14        n.o.
   β                   1.97 m                                                                                                                                                                                        H-12, H-13α, H-14        n.o.
  14                   1.58 m                                                              39.0                                                         \(d\)                                                        H-1, H~2~-13, H-18       n.o.
  15                   1.37 s                                                              22.4                                                         \(q\)                                                                                 C-2, −3, −4
  16a                  5.21 s                                                              115.2                                                        \(t\)                                                        H-16b                    C-6, −8
   b                   5.58 s                                                                                                                                                                                        H-16a                    C-6, −7, −8
  17                   1.68 d (0.8)                                                        22.0                                                         \(q\)                                                        H-12                     C-10, −11, −12
  18                   1.62 m                                                              28.8                                                         \(d\)                                                        H-14, H~3~-19, H~3~-20   C-1, −14
  19                   0.92 d (6.4)                                                        21.3                                                         \(q\)                                                        H-18                     C-14, −18, −20
  20                   0.83 d (6.4)                                                        20.5                                                         \(q\)                                                        H-18                     C-14, −18, −19
  OH-6                 2.84 d (7.2)                                                                                                                                                                                  H-6                      n.o.
  3-OC(O)CH~3~                                                                             171.1                                                        \(s\)                                                                                 
   21 22               2.14 s                                                              20.6                                                         \(q\)                                                                                 C-21
                                                                                           171.4                                                        \(s\)                                                                                 
  4.86 dd (6.8, 6.0)   74.1                                                                \(d\)                                                        H~2~-25                                                      C-23, −25, −26           
  1.91 m               24.3                                                                \(t\)                                                        H-24, H~3~-26                                                C-23, −24, −26           
  1.03 t (7.2)         9.3                                                                 \(q\)                                                        H~2~-25                                                      C-24, −25                

Spectra measured at 400 MHz in CDCl~3~ at 25 °C;

Spectra measured at 100 MHz in CDCl~3~ at 25 °C;

*J* values (in hertz) in parentheses;

Attached protons were deduced by DEPT and HMQC experiments;

n.o. = not observed.

###### 

The stereoview of **1** (generated from computer modeling) and the calculated distances (Å) between selected protons having key NOESY correlations.

  Cladielloide A (1)   H/H       (Å)
  -------------------- --------- ------
                       H-1/H-4   2.59
  H-1/H-10             2.33      
  H-2/H-14             2.45      
  H-2/H~3~-15          2.32      
  H-6/H-5α             2.44      
  H-8α/H-9             2.44      
  H-8β/H-9             2.50      
  H-9/H~3~-17          2.61      

###### 

^1^H and ^13^C NMR data, ^1^H--^1^H COSY, and HMBC correlations for diterpenoid **2**.

  Position             ^1^H [a](#tfn6-marinedrugs-08-02936){ref-type="table-fn"}           ^13^C[b](#tfn7-marinedrugs-08-02936){ref-type="table-fn"}   ^1^H ^1^H COSY                                               HMBC (H→C)               
  -------------------- ------------------------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------ ------------------------ ------------------------------------------------------------
  1                    2.51 m                                                              40.6                                                        \(d\) [d](#tfn9-marinedrugs-08-02936){ref-type="table-fn"}   H-2, H-10, H-14          C-10
  2                    3.90 d (3.6) [c](#tfn8-marinedrugs-08-02936){ref-type="table-fn"}   88.1                                                        \(d\)                                                        H-1                      C-1, −3, −4
  3                                                                                        74.8                                                        \(s\)                                                                                 
  4                    5.21 dd (8.0, 4.0)                                                  73.8                                                        \(d\)                                                        H~2~-5                   C-6, −21
  5α                   2.48 m                                                              34.2                                                        \(t\)                                                        H-4, H-5β, H-6           C-6, −7
   β                   1.97 m                                                                                                                                                                                       H-4, H-5α, H-6           n.o. [e](#tfn10-marinedrugs-08-02936){ref-type="table-fn"}
  6                    4.66 dd (8.8, 3.2)                                                  83.8                                                        \(d\)                                                        H~2~-5                   C-4, −7, −16, −25
  7                                                                                        144.2                                                       \(s\)                                                                                 
  8α                   2.65 dd (14.0, 4.8)                                                 41.4                                                        \(t\)                                                        H-8β, H-9                C-6, −7, −9, −10, −16
   β                   2.46 dd (14.0, 2.0)                                                                                                                                                                          H-8α, H-9                C-6, −7, −9, −10, −16
  9                    4.06 br s                                                           82.4                                                        \(d\)                                                        H~2~-8, H-10             n.o.
  10                   2.58 br s                                                           44.7                                                        \(d\)                                                        H-1, H-9                 C-8, −9, −11
  11                                                                                       131.1                                                       \(s\)                                                                                 
  12                   5.49 m                                                              123.1                                                       \(d\)                                                        H~2~-13, H~3~-17         n.o.
  13α                  2.01 m                                                              22.9                                                        \(t\)                                                        H-12, H-13β, H-14        n.o.
   β                   1.80 m                                                                                                                                                                                       H-12, H-13α, H-14        n.o.
  14                   1.39 m                                                              39.8                                                        \(d\)                                                        H-1, H~2~-13, H-18       C-2
  15                   1.33 s                                                              22.8                                                        \(q\)                                                                                 C-2, −3, −4
  16a                  5.26 s                                                              117.7                                                       \(t\)                                                        H-16b                    C-6, −8
   b                   5.47 s                                                                                                                                                                                       H-16a                    C-6, −7, −8
  17                   1.69 d (1.2)                                                        22.8                                                        \(q\)                                                        H-12                     C-10, −11, −12
  18                   1.80 m                                                              27.8                                                        \(d\)                                                        H-14, H~3~-19, H~3~-20   C-14, −19, −20
  19                   0.94 d (6.8)                                                        21.7                                                        \(q\)                                                        H-18                     C-14, −18, −20
  20                   0.77 d (6.8)                                                        17.5                                                        \(q\)                                                        H-18                     C-14, −19, −20
                                                                                           170.2                                                       \(s\)                                                                                 
  4.87 dd (6.8, 6.0)   74.3                                                                \(d\)                                                       H~2~-23                                                      C-21, −23, −24           
  1.91 m               24.5                                                                \(t\)                                                       H-22, H~3~-24                                                C-21, −22, −24           
  1.02 t (7.2)         9.3                                                                 \(q\)                                                       H~2~-23                                                      C-22, −23                
  6-OC(O)CH~3~                                                                             171.6                                                       \(s\)                                                                                 
   25 26               2.14 s                                                              20.6                                                        \(q\)                                                                                 C-25

Spectra measured at 400 MHz in CDCl~3~ at 25 °C;

Spectra measured at 100 MHz in CDCl~3~ at 25 °C;

*J* values (in hertz) in parentheses;

Attached protons were deduced by DEPT and HMQC experiments;

n.o. = not observed.

###### 

Cytotoxic data of diterpenoids **1** and **2**.

  Compound                                                            Cell lines IC~50~ (μg/mL)                 
  ------------------------------------------------------------------- --------------------------- ------ ------ ------
  **1**                                                               \>40                        \>40   \>40   \>40
  **2**                                                               10.2                        \>40   4.7    \>40
  Doxorubicin [a](#tfn11-marinedrugs-08-02936){ref-type="table-fn"}   0.09                        0.03   0.18   0.11

Doxorubicin was used as a reference compound.

###### 

Inhibitory effects of diterpenoids **1** and **2** on superoxide anion generation and elastase release by human neutrophils in response to FMLP/CB.

  Compound                                                            Superoxide anion   Elastase release
  ------------------------------------------------------------------- ------------------ ------------------
  **1**                                                               (20.5 ± 5.0)       (27.1 ± 4.8)
  **2**                                                               5.9 ± 0.7          6.5 ± 1.9
  DPI [c](#tfn14-marinedrugs-08-02936){ref-type="table-fn"}           0.8 ± 0.2          
  Elastatinal [c](#tfn14-marinedrugs-08-02936){ref-type="table-fn"}                      30.8 ± 5.7

Concentration necessary for 50% inhibition (IC~50~);

Percentage of inhibition (Inh %) at 10 μg/mL;

DPI (diphenylene indonium) and elastatinal were used as reference compounds.
